BNT162b2 vaccine induced variant-specific immunity, safety and risk of Omicron breakthrough infection in children aged 5 to 11 years: a cohort study

BNT162b2 vaccine induced variant-specific immunity, safety and risk of Omicron breakthrough infection in children aged 5 to 11 years: a cohort study

Abstract There is little information on BNT162b2 vaccine-induced variant-specific immunogenicity, safety data and dynamics of breakthrough infections in pediatric populations. We addressed these questions using a prospective two dose BNT162b2 (10 mcg) vaccination cohort study of healthy children 5–1...

Full description

Bibliographic Details
Main Authors: Chee Fu Yung, Nina Le Bert, Kai Qian Kam, Seyed Ehsan Saffari, Chee Wah Tan, Yun Yan Mah, Jinyan Zhang, Aileen Ying-Yan Yeoh, Feng Zhu, Smrithi Hariharaputran, Chia Yin Chong, Antonio Bertoletti, Linfa Wang
Format: Article
Language:English
Published: Nature Portfolio 2023-10-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-44565-x

Internet

https://doi.org/10.1038/s41598-023-44565-x

Similar Items